In a very recent study, butyrate (a short-chain fatty acid) supplementation reduced experimental arthritis severity via an increase in 5-hydroxyindole-3-acetic acid, a Trp metabolite derived from serotonin and agonist of AhR [153]. This evidence concerns the gene AHR and arthritic joint disease.